









Markets
/
Stocks
/
nasdaq-dgx
/

Quest Diagnostics Inc

DGX

182.350USD

-0.390-0.21%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

20.24BMarket Cap

21.16P/E TTM



Quest Diagnostics Inc

182.350

-0.390-0.21%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Quest Diagnostics Inc

Currency: USD Updated: 2026-01-29

Key Insights

Quest Diagnostics Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 2 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 197.72.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quest Diagnostics Inc's Score

Industry at a Glance

Industry Ranking

2 / 75

Overall Ranking

37 / 4540

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Quest Diagnostics Inc Highlights

StrengthsRisks

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.

Overvalued

The company’s latest PE is 21.16, at a high 3-year percentile range.

Held by HACAX

Star Investor HACAX holds 3.14K shares of this stock.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

197.716

Target Price

+7.31%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of Quest Diagnostics Inc is 9.08, ranking 7 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 2.82B, representing a year-over-year increase of 13.18%, while its net profit experienced a year-over-year increase of 8.00%.

Score

Industry at a Glance

Previous score

9.08

Change



Financials

6.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.53

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.71

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.70

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Quest Diagnostics Inc's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of Quest Diagnostics Inc is 6.63, ranking 50 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 21.16, which is 7.16% below the recent high of 22.68 and 23.47% above the recent low of 16.20.

Score

Industry at a Glance

Previous score

6.63

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 2/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of Quest Diagnostics Inc is 7.40, ranking 43 out of 75 in the Healthcare Providers & Services industry. The average price target is 198.00, with a high of 215.00 and a low of 169.18.

Score

Industry at a Glance

Previous score

7.40

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

197.716

Target Price

+7.31%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Quest Diagnostics Inc

DGX

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of Quest Diagnostics Inc is 8.82, ranking 10 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 191.89 and the support level at 171.99, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.83

Change

-0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.108

Buy

RSI(14)

51.252

Neutral

STOCH(KDJ)(9,3,3)

29.287

Sell

ATR(14)

3.694

Low Volatility

CCI(14)

-9.171

Neutral

Williams %R

49.658

Neutral

TRIX(12,20)

0.140

Sell

StochRSI(14)

32.572

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

182.576

Sell

MA10

184.839

Sell

MA20

181.132

Buy

MA50

181.797

Buy

MA100

182.371

Sell

MA200

178.708

Buy

Institutional Confidence

Currency: USD Updated: 2026-01-29

The current institutional shareholding score of Quest Diagnostics Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 99.89%, representing a quarter-over-quarter decrease of 0.33%. The largest institutional shareholder is The Vanguard, holding a total of 14.20M shares, representing 12.77% of shares outstanding, with 2.61% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

14.20M

+0.12%

T. Rowe Price Associates, Inc.

Star Investors

6.84M

-2.74%

BlackRock Institutional Trust Company, N.A.

6.13M

-1.31%

State Street Investment Management (US)

5.22M

+0.75%

Boston Partners

4.04M

+32.80%

JP Morgan Asset Management

3.77M

+0.24%

Geode Capital Management, L.L.C.

3.04M

+1.81%

Victory Capital Management Inc.

2.34M

-16.56%

Dimensional Fund Advisors, L.P.

1.91M

+0.32%

Wells Fargo Advisors

1.76M

-1.70%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quest Diagnostics Inc is 9.69, ranking 1 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.66. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Quest Diagnostics Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.